Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» R&D
R&D
NEC buys OncoImmunity to boost AI-based cancer research
Pharmaforum
Tue, 07/30/19 - 08:04 am
NEC
M&A
OncoImmunity
artificial intelligence
machine learnings
R&D
cancer
Massachusetts General and ElevateBio Ink 10-Year Cell and Gene Therapy Deal
BioSpace
Thu, 07/25/19 - 10:40 pm
Massachusetts General Hospital
ElevateBio
cell therapy
gene therapy
R&D
Roche axes early-phase inflammatory disease drug
Fierce Biotech
Thu, 07/25/19 - 10:31 am
Roche
RG6174
R&D
inflammatory diseases
As Takeda absorbs Shire’s R&D ops, the focus is on replacing a centralized command model with a ‘light touch’ in a restructured global organization
Endpoints
Wed, 07/24/19 - 10:39 am
Takeda
Shire
R&D
restructuring
M&A
Do Biopharma Companies Really Spend More on Marketing Than R&D?
RAPS.org
Tue, 07/23/19 - 07:42 pm
R&D
drug pricing
drug marketing
Barron exhorts GSK scientists to take 'smart risks'
Fierce Biotech
Mon, 07/22/19 - 09:51 am
GSK
drug development
R&D
Hal Barron
risk
NASH-linked gene discovery could inspire new drugs to treat liver damage
Fierce Biotech
Fri, 07/19/19 - 12:50 pm
NASH
R&D
drug development
genetics
liver damage
liver fibrosis
Why Merck is in infectious disease for the long haul
BioCentury
Mon, 07/15/19 - 10:50 pm
Merck
R&D
infectious diseases
antibiotics
10 Life Science Innovators Under 40 to Watch
BioSpace
Thu, 07/11/19 - 09:48 am
R&D
innovation
Everyone agrees this superbug is a threat. Few are willing to fund research to stop it
Stat
Mon, 07/8/19 - 09:42 am
superbugs
Candida auris
fungui
R&D
New Markers For Alzheimer's Disease Could Aid Diagnosis And Speed Up Drug Development
NPR
Fri, 07/5/19 - 01:55 pm
Alzheimer's disease
biomarkers
drug develoment
R&D
diagnostics
ImmunoGen cuts deep to eke out cash for mirvetuximab trial
Fierce Biotech
Thu, 06/27/19 - 11:37 am
Immunogen
R&D
layoffs
Top analyst finds a silver lining in AbbVie’s $63B Allergan buyout — but there’s a catch
Endpoints
Wed, 06/26/19 - 11:51 am
AbbVie
Allergan
M&A
R&D
layoffs
Verona hires ex-GSK researchers for late-phase push in COPD
Fierce Biotech
Tue, 06/25/19 - 09:17 am
Verona Pharma
GSK
COPD
R&D
Azar's Plan To Tie U.S. Drug Prices To Foreign Ones Will Impact Investments In R&D
Forbes
Fri, 06/21/19 - 09:42 am
Alex Azar
drug pricing
R&D
HHS
Sanofi to ax 466 jobs, step up focus on cancer, gene therapy R&D
Fierce Biotech
Thu, 06/20/19 - 09:56 am
Sanofi
layoffs
Germany
France
R&D
immuno-oncology
gene therapy
Schrödinger hires ex-Eisai, Merck staff for push into clinic
Fierce Biotech
Wed, 06/19/19 - 09:51 am
Schrödinger
R&D
Eisai
Merck
biotech
AstraZeneca commits $630M to Korean drug R&D push
Fierce Biotech
Mon, 06/17/19 - 09:58 am
AstraZeneca
South Korea
R&D
Sweden
Research Roundup: A New Protein Linked to Alzheimer’s and Other Highlights
BioSpace
Fri, 06/14/19 - 06:31 pm
R&D
Alzheimer's disease
genetic translation
Merck's Full Court Press On Oncology
Forbes
Fri, 06/14/19 - 06:22 pm
Merck
oncology
R&D
M&A
Tilos Therapeutics
Pages
« first
‹ previous
…
27
28
29
30
31
32
33
34
35
…
next ›
last »